|
[1]BAMBHA K, KIM WR, TALWALKAR J, et al.Incidence, clinical spectrum and outcomes of primary sclerosing cholangitis in a United States community[J].Gastroenterology, 2003, 125 (5) :1364-1369.
|
|
[2]Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary sclerosing cholangitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :23-31. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性硬化性胆管炎诊断和治疗专家共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :23-31.
|
|
[3]MOLODECKY NA, KAREEMI H, PARAB R, et al.Incidence of primary sclerosing cholangitis:a systematic review and meta-analysis[J].Hepatology, 2011, 53 (5) :1590-1599.
|
|
[4]BENITO de VALLE M, RAHMAN M, LINDKVIST B, et al.Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis[J].Clin Gastroenterol Hepatol, 2012, 10 (7) :769-775.
|
|
[5]PORTMANN B, ZEN Y.Inflammatory disease of the bile ducts-cholangiopathies:liver biopsy challenge and clinicopathological correlation[J].Histopathology, 2012, 60 (2) :236-248.
|
|
[6]BOONSTRA K, WEERSMA RK, VALL ERPECUM KJ, et al.Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis[J].Hepatology, 2013, 58 (6) :2045-2055.
|
|
[7]TISCHENDORF JJ, HECKER H, KFIIGER M, et al.Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis:a single center study[J].Am J Gastroenterol, 2007, 102 (1) :107-114.
|
DownLoad: